Bringing natural killer cells to the clinic

Cancer is a leading cause of mortality worldwide, with around 10 million deaths every year. Despite huge advances due to immunotherapy, the majority of cancer patients present primary or secondary resistance to these treatments. In this Found in Translation, we focus on the approaches developed to h...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiossone, Laura, Vivier, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2022
Materias:
Found in Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448638/
https://www.ncbi.nlm.nih.gov/pubmed/36066456
http://dx.doi.org/10.1084/jem.20220830
_version_ 1784784108889571328
author Chiossone, Laura
Vivier, Eric
author_facet Chiossone, Laura
Vivier, Eric
author_sort Chiossone, Laura
collection PubMed
description Cancer is a leading cause of mortality worldwide, with around 10 million deaths every year. Despite huge advances due to immunotherapy, the majority of cancer patients present primary or secondary resistance to these treatments. In this Found in Translation, we focus on the approaches developed to harness the anti-tumor function of NK cells, suggesting promising strategies to complete the therapeutic arsenal of cancer immunotherapies.
format Online
Article
Text
id pubmed-9448638
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-94486382023-03-06 Bringing natural killer cells to the clinic Chiossone, Laura Vivier, Eric J Exp Med Found in Translation Cancer is a leading cause of mortality worldwide, with around 10 million deaths every year. Despite huge advances due to immunotherapy, the majority of cancer patients present primary or secondary resistance to these treatments. In this Found in Translation, we focus on the approaches developed to harness the anti-tumor function of NK cells, suggesting promising strategies to complete the therapeutic arsenal of cancer immunotherapies. Rockefeller University Press 2022-09-06 /pmc/articles/PMC9448638/ /pubmed/36066456 http://dx.doi.org/10.1084/jem.20220830 Text en © 2022 Chiossone and Vivier https://creativecommons.org/licenses/by-nc-sa/4.0/http://www.rupress.org/terms/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Found in Translation
Chiossone, Laura
Vivier, Eric
Bringing natural killer cells to the clinic
title Bringing natural killer cells to the clinic
title_full Bringing natural killer cells to the clinic
title_fullStr Bringing natural killer cells to the clinic
title_full_unstemmed Bringing natural killer cells to the clinic
title_short Bringing natural killer cells to the clinic
title_sort bringing natural killer cells to the clinic
topic Found in Translation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448638/
https://www.ncbi.nlm.nih.gov/pubmed/36066456
http://dx.doi.org/10.1084/jem.20220830
work_keys_str_mv AT chiossonelaura bringingnaturalkillercellstotheclinic
AT viviereric bringingnaturalkillercellstotheclinic

Ejemplares similares